Skip to main content
Figure 2 | Journal of Translational Medicine

Figure 2

From: A pilot clinical trial testing mutant von Hippel-Lindau peptide as a novel immune therapy in metastatic Renal Cell Carcinoma

Figure 2

Regulatory T cells (T regs). The percentage of T regulatory cells (CD4+CD25+FoxP3+) measured in the peripheral blood of the evaluable patients (patient 2, 3, 4, 5, and 6) pre and postvaccination. The postvaccination samples were taken during the last vaccination visit for every patient except patient 3 whom the last available T regs sample was during vaccination 5.

Back to article page